Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment.

Maillard JY, Bloomfield S, Coelho JR, Collier P, Cookson B, Fanning S, Hill A, Hartemann P, McBain AJ, Oggioni M, Sattar S, Schweizer HP, Threlfall J.

Microb Drug Resist. 2013 Oct;19(5):344-54. doi: 10.1089/mdr.2013.0039. Epub 2013 Jun 14. Review.

PMID:
23768140
2.

Biofilm inhibition and antimicrobial action of lipopeptide biosurfactant produced by heavy metal tolerant strain Bacillus cereus NK1.

Sriram MI, Kalishwaralal K, Deepak V, Gracerosepat R, Srisakthi K, Gurunathan S.

Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):174-81. doi: 10.1016/j.colsurfb.2011.02.026. Epub 2011 Feb 26.

PMID:
21458961
3.

Role of antibiofilm-antimicrobial agents in controlling device-related infections.

Aslam S, Darouiche RO.

Int J Artif Organs. 2011 Sep;34(9):752-8. doi: 10.5301/ijao.5000024.

4.
5.

Antibiotic resistance: from Darwin to Lederberg to Keynes.

Amábile-Cuevas CF.

Microb Drug Resist. 2013 Apr;19(2):73-87. doi: 10.1089/mdr.2012.0115. Epub 2012 Oct 9.

PMID:
23046150
6.

Effect of DNase and antibiotics on biofilm characteristics.

Tetz GV, Artemenko NK, Tetz VV.

Antimicrob Agents Chemother. 2009 Mar;53(3):1204-9. doi: 10.1128/AAC.00471-08. Epub 2008 Dec 8.

7.

Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg?

Martínez JL, Alonso A, Gómez-Gómez JM, Baquero F.

J Antimicrob Chemother. 1998 Dec;42(6):683-8. Review. No abstract available.

8.

Adenylate kinase release as a high-throughput-screening-compatible reporter of bacterial lysis for identification of antibacterial agents.

Jacobs AC, Didone L, Jobson J, Sofia MK, Krysan D, Dunman PM.

Antimicrob Agents Chemother. 2013 Jan;57(1):26-36. doi: 10.1128/AAC.01640-12. Epub 2012 Oct 1.

9.

Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria.

Shen J, Wang Y, Schwarz S.

J Antimicrob Chemother. 2013 Aug;68(8):1697-706. doi: 10.1093/jac/dkt092. Epub 2013 Mar 29. Review.

10.

New trends in pharmacogenomic strategies against resistance development in microbial infections.

Ohlsen K, Dandekar G, Schwarz R, Dandekar T.

Pharmacogenomics. 2008 Nov;9(11):1711-23. doi: 10.2217/14622416.9.11.1711. Review.

PMID:
19018725
11.

Novel antimicrobial agents against multi-drug-resistant gram-negative bacteria: an overview.

Karras G, Giannakaki V, Kotsis V, Miyakis S.

Recent Pat Antiinfect Drug Discov. 2012 Dec 1;7(3):175-81. Review.

PMID:
23061790
12.

[Experimental study of combination of ciprofloxacin and oxytocin on formation of biofilms by opportunistic bacteria].

Skorobogatykh IuI, Perunova NB, Kurlaev PP, Bukharin OV.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Nov-Dec;(6):3-7. Russian.

PMID:
21384587
13.

Antimicrobial activity of enoxacin.

Nicoletti G, Caccamo F, Speciale A.

J Chemother. 1989 Jul;1(4 Suppl):143-4. No abstract available.

PMID:
16312344
14.

In vitro activity of faropenem compared with eight agents against fourteen Gram-positive and Gram-negative bacteria by time-kill.

Credito KL, Jacobs MR, Appelbaum PC.

J Antimicrob Chemother. 2003 Jun;51(6):1437-9. Epub 2003 May 13. No abstract available.

15.

Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.

Sutcliffe JA, O'Brien W, Fyfe C, Grossman TH.

Antimicrob Agents Chemother. 2013 Nov;57(11):5548-58. doi: 10.1128/AAC.01288-13. Epub 2013 Aug 26.

16.

Biocide activity against urinary catheter pathogens.

Malic S, Jordan RP, Waters MG, Stickler DJ, Williams DW.

Antimicrob Agents Chemother. 2014;58(2):1192-4. doi: 10.1128/AAC.01106-13. Epub 2013 Nov 18.

17.

Bacterial resistance and topical antimicrobial wash products.

Jones RD.

Am J Infect Control. 1999 Aug;27(4):351-63. Review.

PMID:
10433675
18.

Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria.

Butaye P, Cloeckaert A, Schwarz S.

Int J Antimicrob Agents. 2003 Sep;22(3):205-10. Review.

PMID:
13678822
19.

Targets for Combating the Evolution of Acquired Antibiotic Resistance.

Culyba MJ, Mo CY, Kohli RM.

Biochemistry. 2015 Jun 16;54(23):3573-82. doi: 10.1021/acs.biochem.5b00109. Epub 2015 Jun 5. Review.

20.

The affect of pH and bacterial phenotypic state on antibiotic efficacy.

Thomas J, Linton S, Corum L, Slone W, Okel T, Percival SL.

Int Wound J. 2012 Aug;9(4):428-35. doi: 10.1111/j.1742-481X.2011.00902.x. Epub 2011 Dec 19.

PMID:
22182197
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk